147 related articles for article (PubMed ID: 37902676)
21. Stabilizer-Guided Inhibition of Protein-Protein Interactions.
Milroy LG; Bartel M; Henen MA; Leysen S; Adriaans JM; Brunsveld L; Landrieu I; Ottmann C
Angew Chem Int Ed Engl; 2015 Dec; 54(52):15720-4. PubMed ID: 26537010
[TBL] [Abstract][Full Text] [Related]
22. An Exploration of Chemical Properties Required for Cooperative Stabilization of the 14-3-3 Interaction with NF-κB-Utilizing a Reversible Covalent Tethering Approach.
Wolter M; Valenti D; Cossar PJ; Hristeva S; Levy LM; Genski T; Hoffmann T; Brunsveld L; Tzalis D; Ottmann C
J Med Chem; 2021 Jun; 64(12):8423-8436. PubMed ID: 34076416
[TBL] [Abstract][Full Text] [Related]
23. Selectivity via Cooperativity: Preferential Stabilization of the p65/14-3-3 Interaction with Semisynthetic Natural Products.
Wolter M; de Vink P; Neves JF; Srdanović S; Higuchi Y; Kato N; Wilson A; Landrieu I; Brunsveld L; Ottmann C
J Am Chem Soc; 2020 Jul; 142(27):11772-11783. PubMed ID: 32501683
[TBL] [Abstract][Full Text] [Related]
24. Development of a NanoBRET assay for evaluation of 14-3-3σ molecular glues.
Vickery HR; Virta JM; Konstantinidou M; Arkin MR
SLAS Discov; 2024 May; ():100165. PubMed ID: 38797286
[TBL] [Abstract][Full Text] [Related]
25. Rationally Designed Semisynthetic Natural Product Analogues for Stabilization of 14-3-3 Protein-Protein Interactions.
Andrei SA; de Vink P; Sijbesma E; Han L; Brunsveld L; Kato N; Ottmann C; Higuchi Y
Angew Chem Int Ed Engl; 2018 Oct; 57(41):13470-13474. PubMed ID: 30025189
[TBL] [Abstract][Full Text] [Related]
26. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface.
Bier D; Bartel M; Sies K; Halbach S; Higuchi Y; Haranosono Y; Brummer T; Kato N; Ottmann C
ChemMedChem; 2016 Apr; 11(8):911-8. PubMed ID: 26644359
[TBL] [Abstract][Full Text] [Related]
27. In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.
Singh K; Munuganti RS; Leblanc E; Lin YL; Leung E; Lallous N; Butler M; Cherkasov A; Rennie PS
Breast Cancer Res; 2015 Feb; 17(1):27. PubMed ID: 25848700
[TBL] [Abstract][Full Text] [Related]
28. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
[TBL] [Abstract][Full Text] [Related]
29. Small molecules modulation of 14-3-3 protein-protein interactions.
Mori M; Vignaroli G; Botta M
Drug Discov Today Technol; 2013 Dec; 10(4):e541-7. PubMed ID: 24451646
[TBL] [Abstract][Full Text] [Related]
30. Developing Antagonists for the Met-HGF/SF Protein-Protein Interaction Using a Fragment-Based Approach.
Winter A; Sigurdardottir AG; DiCara D; Valenti G; Blundell TL; Gherardi E
Mol Cancer Ther; 2016 Jan; 15(1):3-14. PubMed ID: 26712116
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein-protein interaction-oriented library and machine learning.
Shimizu Y; Yonezawa T; Sakamoto J; Furuya T; Osawa M; Ikeda K
Sci Rep; 2021 Apr; 11(1):7420. PubMed ID: 33795749
[TBL] [Abstract][Full Text] [Related]
32. Hotspot Identification and Drug Design of Protein-Protein Interaction Modulators Using the Fragment Molecular Orbital Method.
Monteleone S; Fedorov DG; Townsend-Nicholson A; Southey M; Bodkin M; Heifetz A
J Chem Inf Model; 2022 Aug; 62(16):3784-3799. PubMed ID: 35939049
[TBL] [Abstract][Full Text] [Related]
33. Fragment-based exploration of the 14-3-3/Amot-p130 interface.
Centorrino F; Andlovic B; Cossar P; Brunsveld L; Ottmann C
Curr Res Struct Biol; 2022; 4():21-28. PubMed ID: 35036934
[TBL] [Abstract][Full Text] [Related]
34. Stabilization of Protein-Protein Interactions in chemical biology and drug discovery.
Bier D; Thiel P; Briels J; Ottmann C
Prog Biophys Mol Biol; 2015 Oct; 119(1):10-9. PubMed ID: 26093250
[TBL] [Abstract][Full Text] [Related]
35. 14-3-3: A Case Study in PPI Modulation.
Ballone A; Centorrino F; Ottmann C
Molecules; 2018 Jun; 23(6):. PubMed ID: 29890630
[TBL] [Abstract][Full Text] [Related]
36. Natural products used as a chemical library for protein-protein interaction targeted drug discovery.
Jin X; Lee K; Kim NH; Kim HS; Yook JI; Choi J; No KT
J Mol Graph Model; 2018 Jan; 79():46-58. PubMed ID: 29136547
[TBL] [Abstract][Full Text] [Related]
37. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
[TBL] [Abstract][Full Text] [Related]
38. Cooperativity basis for small-molecule stabilization of protein-protein interactions.
de Vink PJ; Andrei SA; Higuchi Y; Ottmann C; Milroy LG; Brunsveld L
Chem Sci; 2019 Mar; 10(10):2869-2874. PubMed ID: 30996864
[TBL] [Abstract][Full Text] [Related]
39. In silico identification of novel inhibitors targeting the DNA-binding domain of the human estrogen receptor alpha.
Cao H; Sun Y; Wang L; Pan Y; Li Z; Liang Y
J Steroid Biochem Mol Biol; 2021 Oct; 213():105966. PubMed ID: 34416373
[TBL] [Abstract][Full Text] [Related]
40. Molecular glues for protein-protein interactions: Progressing toward a new dream.
Konstantinidou M; Arkin MR
Cell Chem Biol; 2024 Jun; 31(6):1064-1088. PubMed ID: 38701786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
